Vivo Bio Tech gets nod to acquire Donakanti Consultancy Services

18 Apr 2019 Evaluate

Vivo Bio Tech has received approval from its board for acquiring 100% stake in Donakanti Consultancy Services. The current investment of Rs 3.18 crore, will help the company to acquire E-governance projects with the Government of India.

Vivo Bio Tech is a contract research company engaged in biotechnology and pharma drug discovery activities. VBTL provides services ranging from insilico design, wet lab contract research, preclinical research and clinical studies spanning the entire drug discovery value chain.

Vivo Bio Tech Share Price

30.65 -0.01 (-0.03%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×